A fully liquid DTaP-IPV-HB-PRP-T hexavalent vaccine for primary and booster vaccination of healthy Turkish infants and toddlers


Creative Commons License

CEYHAN M., Yildirim I., Tezer H., Devrim I., Feroldi E.

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.47, no.4, pp.1247-1256, 2017 (SCI-Expanded) identifier identifier identifier

Abstract

Background/aim: Immunogenicity and safety of a primary series of a fully liquid, hexavalent DTaP-IPV-HB-PRP-T vaccine given at 2, 3, and 4 months of age compared to licensed comparators and a DTaP-IPV-HB-PRP-T booster at 15-18 months were evaluated.